Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT04533620
Eligibility Criteria:
Inclusion Criteria:
* Aged between 17-70 years.
* Pathologically diagnosed as WHO type 2/3 nasopharyngeal carcinoma.
* Failed previous definitive radiotherapy at least 6 months ago.
* Only had 1 previous course of radiotherapy.
* Eastern Cooperative Oncology Group score: 0-1.
* Adequate laboratory values within 30 dyas of enrollment to study defined as follows: 1) neutrophil \> 2000/mm\^3; 2) platelet \> 100,000/mm\^3; 3) total bilirubin \< 1.5mg/dl; 4) alanine aminotransferase/aspartate aminotransferase \< 1.5 upper limit of normal; 5) SCr \< 1.5mg/dl; creatinine clearance rate \> 60ml/min.
* Willing to accept adequate contraception for women with childbearing potential.
* Willing to sign the written informed consent; Informed consent must be signed before the enrollment in the trial.
Exclusion Criteria:
* Presence of distant metastasis.
* Without measurable lesion.
* Previous history of malignant tumor (within 5 years) or simultaneous existence of multiple primary tumors.
* Accompanied with severe major organ dysfunction.
* Presence of mental disease that may influence the understanding of informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT04533620
Study Brief:
Protocol Section:
NCT04533620